常见的NAD(P)H醌氧化还原酶多态性患病率的种族差异及其对抗癌化疗的影响。
Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy.
作者信息
Kelsey K T, Ross D, Traver R D, Christiani D C, Zuo Z F, Spitz M R, Wang M, Xu X, Lee B K, Schwartz B S, Wiencke J K
机构信息
Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115, USA.
出版信息
Br J Cancer. 1997;76(7):852-4. doi: 10.1038/bjc.1997.474.
Abstract
The NAD(P)H quinone oxidoreductase (NQO1:EC 1.6.99.2) is an important biotransformation enzyme system that is also known to metabolize important novel chemotherapeutic compounds. The gene that codes for this enzyme has recently been found to be polymorphic in humans. Here, we describe the ethnic distribution of the polymorphism and note that this may have implications for anti-tumour drug development and use.
摘要
烟酰胺腺嘌呤二核苷酸磷酸（NAD(P)H）醌氧化还原酶（NQO1：EC 1.6.99.2）是一种重要的生物转化酶系统，已知它还能代谢重要的新型化疗化合物。最近发现，编码该酶的基因在人类中具有多态性。在此，我们描述了这种多态性的种族分布，并指出这可能对抗肿瘤药物的研发和使用产生影响。
相似文献
1
Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy.常见的NAD(P)H醌氧化还原酶多态性患病率的种族差异及其对抗癌化疗的影响。
Br J Cancer. 1997;76(7):852-4. doi: 10.1038/bjc.1997.474.
2
NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.NAD(P)H：醌氧化还原酶1和NRH：醌氧化还原酶2在膀胱癌和卵巢癌中的活性及表达，以及与NQO2外显子3单核苷酸多态性相关的较低的NRH：醌氧化还原酶2活性。
Clin Cancer Res. 2007 Mar 1;13(5):1584-90. doi: 10.1158/1078-0432.CCR-06-1416.
3
Quinone reductases multitasking in the metabolic world.醌还原酶在代谢世界中的多重任务
Drug Metab Rev. 2004 Oct;36(3-4):639-54. doi: 10.1081/dmr-200033465.
4
An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2.特发性帕金森病与Ⅱ相解毒酶多态性之间的关联：谷胱甘肽S-转移酶M1以及醌氧化还原酶1和2
Biochem Biophys Res Commun. 2001 Nov 9;288(4):887-92. doi: 10.1006/bbrc.2001.5868.
5
No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.帕金森病与醌氧化还原酶（NQO1、NQO2）基因多态性之间无关联。
Neurosci Lett. 2005 Mar 3;375(3):178-80. doi: 10.1016/j.neulet.2004.11.009. Epub 2004 Dec 10.
6
Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis.NQO1 609C>T 和 NQO2 -3423G>A 多态性与印度北部人群食管癌易感性和预后的相关性研究及荟萃分析。
Cancer Epidemiol. 2012 Dec;36(6):e373-9. doi: 10.1016/j.canep.2012.06.004. Epub 2012 Jul 6.
7
The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.烟酰胺腺嘌呤二核苷酸磷酸（NAD(P)H）：醌氧化还原酶1基因多态性与肺癌：基于吸烟行为的易感性差异
Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):303-9.
8
[Polymorphism of MAO-B gene and NAD(P)H: quinone oxidoreductase gene in Parkinson's disease].[帕金森病中MAO - B基因与NAD(P)H：醌氧化还原酶基因的多态性]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001 Apr;18(2):122-4.
9
Free radicals in toxicology: redox cycling and NAD(P)H:quinone oxidoreductase.毒理学中的自由基：氧化还原循环与NAD(P)H：醌氧化还原酶
Arch Toxicol Suppl. 1996;18:217-22. doi: 10.1007/978-3-642-61105-6_22.
10
[Quinone oxidoreductase gene polymorphism and genetic susceptibility to nasopharyngeal carcinoma].[醌氧化还原酶基因多态性与鼻咽癌的遗传易感性]
Di Yi Jun Yi Da Xue Xue Bao. 2002 Dec;22(12):1126-7.
引用本文的文献
1
Loss-of-function polymorphisms in NQO1 are not associated with the development of subacute myelo-optico-neuropathy.NQO1 基因失活多态性与亚急性脊髓视神经病的发生无关。
Mol Genet Genomic Med. 2024 Jun;12(6):e2470. doi: 10.1002/mgg3.2470.
2
Roles of NAD(P)H:quinone Oxidoreductase 1 in Diverse Diseases.NAD(P)H：醌氧化还原酶1在多种疾病中的作用。
Life (Basel). 2021 Nov 26;11(12):1301. doi: 10.3390/life11121301.
3
Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compound.NQO1 激活化合物对泛素蛋白酶体系统的抑制作用。
Cell Death Dis. 2021 Oct 6;12(10):914. doi: 10.1038/s41419-021-04191-9.
4
The Analysis of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Polish Patients with Colorectal Cancer.波兰结直肠癌患者的 NADPH 醌氧化还原酶 1（NQO1）多态性分析。
Biomolecules. 2021 Jul 14;11(7):1024. doi: 10.3390/biom11071024.
5
Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapy.利用猫口腔鳞状细胞癌患者开发 NQO1 靶向治疗。
Neoplasia. 2021 Aug;23(8):811-822. doi: 10.1016/j.neo.2021.06.008. Epub 2021 Jul 8.
6
Limonin induces apoptosis of HL-60 cells by inhibiting NQO1 activity.柠檬苦素通过抑制NQO1活性诱导HL-60细胞凋亡。
Food Sci Nutr. 2021 Mar 2;9(4):1860-1869. doi: 10.1002/fsn3.2109. eCollection 2021 Apr.
7
The diverse functionality of NQO1 and its roles in redox control.NQO1 的多样化功能及其在氧化还原控制中的作用。
Redox Biol. 2021 May;41:101950. doi: 10.1016/j.redox.2021.101950. Epub 2021 Mar 20.
8
A small molecule chaperone rescues the stability and activity of a cancer-associated variant of NAD(P)H:quinone oxidoreductase 1 in vitro.小分子伴侣可在体外恢复与癌症相关的 NAD(P)H：醌氧化还原酶 1 变体的稳定性和活性。
FEBS Lett. 2020 Feb;594(3):424-438. doi: 10.1002/1873-3468.13636. Epub 2019 Oct 30.
9
Joint effect of smoking and NQO1 C609T polymorphism on undifferentiated nasopharyngeal carcinoma risk in a North African population.吸烟与NQO1基因C609T多态性对北非人群未分化鼻咽癌风险的联合影响。
Mol Genet Genomic Med. 2018 Nov;6(6):933-940. doi: 10.1002/mgg3.461. Epub 2018 Aug 29.
10
Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials.MB12066的药代动力学和耐受性，一种靶向NAD(P)H：醌氧化还原酶1的β-拉帕醌衍生物：两项独立、双盲、安慰剂对照、单次和多次递增剂量的首次人体临床试验。
Drug Des Devel Ther. 2017 Nov 7;11:3187-3195. doi: 10.2147/DDDT.S151269. eCollection 2017.
本文引用的文献
1
A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity.NAD（P）H：醌氧化还原酶（NQO1）的多态性：NQO1 cDNA第609位纯合突变与NQO1活性的关系。
Br J Cancer. 1996 Sep;74(6):995-6. doi: 10.1038/bjc.1996.477.
2
Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9.国立癌症研究所肿瘤细胞系面板中的还原酶表达：与对丝裂霉素C和EO9敏感性的相关性
J Natl Cancer Inst. 1996 Mar 6;88(5):259-69. doi: 10.1093/jnci/88.5.259.
3
Cancer in Hispanics: issues of concern.西班牙裔人群中的癌症：相关关注问题
J Natl Cancer Inst Monogr. 1995(18):35-9.
4
DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C.DT-黄递酶在醌类的激活与解毒过程中的作用。丝裂霉素C的生物还原激活作用。
Cancer Metastasis Rev. 1993 Jun;12(2):83-101. doi: 10.1007/BF00689803.
5
Secondary leukaemia after MMM combined modality therapy for breast carcinoma.乳腺癌采用乳房改良根治术联合综合治疗后的继发性白血病
Lancet. 1993 May 15;341(8855):1289. doi: 10.1016/0140-6736(93)91199-v.
6
Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.美国白人、西班牙裔和黑人女性的肿瘤生物学因素与乳腺癌预后
J Natl Cancer Inst. 1994 May 4;86(9):705-12. doi: 10.1093/jnci/86.9.705.
7
Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies.醌由DT-黄递酶进行的生物活化：分子、生化及化学研究
Oncol Res. 1994;6(10-11):493-500.
8
Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase.酶导向生物还原药物研发再探讨：关于近期进展及未来前景的评论，重点关注醌类抗癌剂和醌代谢酶，尤其是DT-二氢嘧啶脱氢酶。
Oncol Res. 1994;6(10-11):461-75.
9
Re: Detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer.关于：一名结肠癌患者中NQO1（DT-黄递酶）点突变的检测
J Natl Cancer Inst. 1995 Dec 6;87(23):1802-3. doi: 10.1093/jnci/87.23.1802.
Zotero 插件